Abbott files Hatch-Waxman case against Impax over Trilipix
Trilipix is a drug designed to raise "good" cholesterol while lowering "bad" cholesterol and triglycerides. Impax did a paragraph IV Hatch-Waxman filing and Abbott filed an infringement suit against Impax.
As to stock prices, Impax stock rose 38 cents, or 2.3 percent, to $16.87. Shares of Chicago-based Abbott lost 15 cents to $54.37.
As to stock prices, Impax stock rose 38 cents, or 2.3 percent, to $16.87. Shares of Chicago-based Abbott lost 15 cents to $54.37.
posted by Lawrence B. Ebert at 2:35 PM
0 Comments:
Post a Comment
<< Home